Loading...
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial
BACKGROUND: Few data are available on the benefit of metronomic cyclophosphamide, capecitabine, and vinorelbine as first-line therapy in patients with metastatic triple-negative breast cancer. METHODS: This phase II study assessed the safety and efficacy of metronomic oral chemotherapy with vinorelb...
Na minha lista:
| Udgivet i: | Breast Care (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger GmbH
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6062718/ https://ncbi.nlm.nih.gov/pubmed/30069178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487630 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|